ASCO 2011|May 25, 2011 4:11 am

ASCO 2011 ….. is coming


 

The American Society of Clinical Oncology (ASCO) meeting is coming! It begins on Friday June 3 in Chicago and continues through Tuesday June 7.

This year, we “celebrated” Embargo Day on Wednesday May 18. This is the day when almost all of the abstracts are released, and the plenary and oral abstract session titles are published. This year, for the unprecedented second year in a row, two abstracts on melanoma will be presented at the Plenary Session, Sunday afternoon, June 5. Last year, it was the positive study on Ipi in second line therapy for Stage IV melanoma. This year, the other Ipi (now Yervoy) study, comparing front-line treatment with Ipi/DTIC to DTIC alone will be presented by Jedd Wolchok, MD of Sloan Kettering. The other Plenary melanoma paper will be the BRIM-3 study results, where patients with the v600e BRAF mutation were treated with PLX4032/RG7204 vs DTIC. This paper will be presented by Paul Chapman, MD, also of Sloan Kettering. We know both showed positive results; we don’t yet know the magnitude.

I will be analyzing the potential results soon; check back for updates. Please note I have no personal knowledge of the results, and was not a PI on either study.

In the meantime, use this link to search on melanoma related talks and posters at ASCO.

Eric D. Whitman, MD

Senior Editor, TheMelanomaCenter.com


Tags:
  • Share this post:
  • Facebook
  • Twitter
  • Delicious
  • Digg
Shopping Cart (0 Items)
Your cart is empty!


Subtotal: $0.00
Total: $0.00